Fosfomycin Dosing in Late 80s Patient with eGFR 38 mL/min
Use the standard single 3-gram oral dose of fosfomycin without any dose adjustment for this patient, as no renal dose modification is required even with moderate renal impairment (eGFR 38 mL/min). 1
Dosing Recommendation
Standard dose applies: Administer one 3-gram sachet of fosfomycin tromethamine as a single oral dose, which is the FDA-approved regimen for uncomplicated urinary tract infections in adults. 1
No geriatric adjustment needed: The FDA label explicitly states that no dosage adjustment is necessary in elderly patients based on 24-hour urinary drug concentration data. 1
No renal adjustment required: Despite the patient's eGFR of 38 mL/min (CKD Stage 3), fosfomycin does not require dose modification. The FDA label confirms that fosfomycin can be used across varying degrees of renal impairment without dose adjustment for the standard single-dose regimen. 1
Pharmacokinetic Rationale
Adequate urinary concentrations maintained: In elderly patients with impaired renal function (mean creatinine clearance 40 mL/min—nearly identical to your patient), urinary fosfomycin concentrations remained 1,383 mg/L in the first 12 hours and 165 mg/L at 36-48 hours, well above the MIC for common uropathogens. 2
Extended elimination benefits this population: The elimination half-life increases from 5.7 hours in normal renal function to 11-24 hours in patients with renal impairment (creatinine clearance 7-54 mL/min), which actually prolongs therapeutic urinary concentrations rather than causing toxicity concerns. 1, 2
Therapeutic levels persist despite reduced clearance: Even in patients with severe renal insufficiency and high plasma creatinine, urinary concentrations consistently exceed 100 mcg/mL regardless of the degree of renal impairment. 3
Administration Instructions
Mix with water before ingestion: Never administer fosfomycin in dry form; always dissolve the sachet contents in water before the patient drinks it. 1
Food does not matter: Fosfomycin can be taken with or without food, as fed versus fasting states do not alter the cumulative urinary excretion or duration of therapeutic concentrations (both maintain levels ≥100 mcg/mL for 26 hours). 1
Safety Considerations
No systemic toxicity concern: Fosfomycin demonstrates absence of renal and systemic toxicity even in patients with very high plasma creatinine, allowing the daily dosage to remain unchanged regardless of renal insufficiency degree. 3
Favorable safety profile in elderly: Clinical experience confirms fosfomycin's minimal side effects and broad tolerability in older populations, contributing to high patient compliance. 4, 5
Common Pitfall to Avoid
Do not confuse with IV fosfomycin dosing: The evidence discussing 12-24 g/day IV fosfomycin regimens for critically ill patients or those on dialysis 6, 7, 8 is irrelevant to your patient receiving oral fosfomycin for uncomplicated cystitis. The single 3-gram oral dose remains appropriate and requires no modification. 1
Do not withhold due to renal function: Unlike nitrofurantoin (contraindicated at eGFR <30 mL/min) 9, 10, fosfomycin remains safe and effective at eGFR 38 mL/min with standard dosing.